Remediation of undesirable secondary interactions encountered in hydrophilic interaction chromatography during development of a quantitative LC-MS/MS assay for a dipeptidyl peptidase IV (DPP-IV) inhibitor in monkey serum

スポンサーリンク

概要

• 論文の詳細を見る
• 2009-02-15

著者

• Kadar Eugene

  Pharmacokinetics Dynamics & Metabolism Pfizer Global Research And Development Pfizer Inc.

• Wujcik Chad

  Monsanto 800 North Lindbergh Boulevard

• KADAR Eugene

  Pharmacokinetics, Dynamics & Metabolism, Pfizer Global Research and Development, Pfizer, Inc.

関連論文

• Rapid determination of the applicability of hydrophilic interaction chromatography utilizing ACD Labs Log D Suite : A bioanalytical application
• Remediation of undesirable secondary interactions encountered in hydrophilic interaction chromatography during development of a quantitative LC-MS/MS assay for a dipeptidyl peptidase IV (DPP-IV) inhibitor in monkey serum

スポンサーリンク